Cargando…

Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option

Detalles Bibliográficos
Autores principales:	Leclerc, Julie, Ayav, Ahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial from the ACHBPT
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745628/ https://www.ncbi.nlm.nih.gov/pubmed/36523944 http://dx.doi.org/10.21037/hbsn-22-511

Ejemplares similares

Editorial on “Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a propensity score matching analysis”
por: Gugenheim, Jean, et al.
Publicado: (2022)

Pancreatic enucleation: a valid surgical option with encouraging quality of life
por: Cherkaoui, Zineb, et al.
Publicado: (2023)

Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”
por: Khayat, Salah, et al.
Publicado: (2022)

Feasibility, safety and limits of robotic approach for lymphadenectomy in biliary tumours
por: Deyrat, Julie, et al.
Publicado: (2023)

Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care
por: de Ponthaud, Charles, et al.
Publicado: (2022)

Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea
por: Chebaro, Alexandre, et al.
Publicado: (2023)

Postoperative pancreatic fistula after distal pancreatectomy: pancreatic thickness and duct size as the only denominators?
por: Notte, Antoine, et al.
Publicado: (2023)

Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?
por: Sommier, Lazare, et al.
Publicado: (2023)

Utility of circulating tumor DNA in patients undergoing hepatectomy for colorectal liver metastases
por: Cnockaert, Philippine, et al.
Publicado: (2023)

Modified Appleby: experience improves short-term results, but is it enough?
por: Marichez, Arthur, et al.
Publicado: (2023)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

Treatment options of metastatic and nonmetastatic VIPoma: a review
por: Azizian, Azadeh, et al.
Publicado: (2022)

Long-term prognosis and management of hepatocellular carcinoma after curative treatment
por: Nishida, Naoshi
Publicado: (2020)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Radiofrequency Ablation Combined with Resection Enhances Chance for Curative Treatment of Hepatocellular Carcinoma
por: Poon, Ronnie T. P.
Publicado: (2007)

Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
por: Obed, Aiman, et al.
Publicado: (2007)

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer
por: Hong, Tingting, et al.
Publicado: (2020)

Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)
por: Villers, A, et al.
Publicado: (2003)

New Therapeutic Options for Advanced Hepatocellular Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

Is Hartmann’s Pouch an Option in the Management of Acute Severe Ulcerative Colitis?
por: Renaud, Myriam, et al.
Publicado: (2022)

Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment
por: Kim, Tae Hyung, et al.
Publicado: (2019)

The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib
por: Conroy, Guillaume, et al.
Publicado: (2017)

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)
por: Mauriac, L, et al.
Publicado: (2003)

Cyclosporine is a potential curative treatment option for advanced thymoma
por: Isshiki, Yusuke, et al.
Publicado: (2017)

Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
por: Kim, Hyo-Cheol
Publicado: (2023)

Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
por: Henriquez, Ivan, et al.
Publicado: (2021)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Curative treatment of oesophageal carcinoma: current options and future developments
por: Wolf, Maria C, et al.
Publicado: (2011)

Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers
por: Gabbia, Daniela, et al.
Publicado: (2023)

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
por: Hao, Ke, et al.
Publicado: (2009)

Parietal and peritoneal localizations of hepatocellular carcinoma: is there a place for a curative surgery?
por: Portolani, Nazario, et al.
Publicado: (2014)

Chemotherapy in Nonmetastatic Osteosarcoma: Recent Advances and Implications for Developing Countries
por: Rastogi, Sameer, et al.
Publicado: (2017)

Development of conversion therapy for advanced hepatocellular carcinoma
por: Matsuki, Ryota, et al.
Publicado: (2023)

Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients
por: Tang, Justin Y., et al.
Publicado: (2018)

Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma
por: Shao, Yanxiang, et al.
Publicado: (2019)

Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma
por: Zhang, Lu-Lu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_loeeubamdqbu2onhsbuaeua8as